The Centre for Genomics and Personalised Health Innovation Grants scheme funds researchers to undertake innovative and collaborative research projects to enable the generation of new preliminary data to support research outputs. It is expected that the data generated from this scheme will result in a research grant or fellowship application to an external competitive funding body and publications.
Congratulations to the following CGPH investigators who were successful in the 2023 Innovation Grant round:
- Dr Mark Adams “Innovative delivery of a novel therapeutic to reverse therapy resistance in EGFR mutant non-small cell lung cancer”
- A/Prof Divya Mehta “Innovative statistical genomics methodologies: Development, implementation, and training”
- Prof Nathan Subramaniam “Understanding the novel role of SARA in liver fibrosis development”
- A/Prof Daniel Wallace “A functional screen of genetic variants using mass prime editing – a proof-of-concept study”
- Dr Jo Voisey “DECoDe PGx: Developing Education Co-designed with community to Decipher pharmacogenomics (PGx)”
- Dr Adrian Wiegmans “Evaluation of Antagomir activity to reverse chemoresistance in vivo and spatial profiling of tumour aetiology for new treatment options”
- Prof Ken O’Byrne “Multi-Omic Peripheral Profiling of Early-stage Lung cancers: The MOPPEL study”
- Prof Rik Thompson “Heparanase Inhibition Towards Personalised Therapy in Pancreatic Cancer”
- Dr Jenni Gunter “Novel metabolic strategy to combat treatment resistance in prostate cancer”
- A/Prof Elizabeth Williams “Piloting plasma and urine personalised cell-free tumour DNA as precision biomarkers for monitoring for bladder cancer recurrence and progression”